Taylor Smith
Taylor Smith
+1.203.905.4506

Overview

Garland Taylor Smith is an attorney based in Holland & Knight's Chattanooga office and a member of the Corporate Services and Venture Capital Teams. Mr. Smith advises clients in mergers, acquisitions, private equity and venture capital financings.

Mr. Smith advises investors in venture capital and private equity transactions, mergers and acquisitions (M&A) and provides business advice to clients making direct minority investments (venture and private equity) and acquisition financing.

Representative Experience

  • Represented a private equity-backed clinical stage biopharmaceutical company focused on ocular drug development in its sale to a publicly traded ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for rare ophthalmic diseases
  • Represented EmVenio Research Inc., the largest provider of community-based clinical trial sites served with mobile research units, in its sale to PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials
  • Represented a client as buyer in the acquisition of a majority of the equity of Florida One Insurance Agency LLC, a Delaware limited liability company; the transaction involved a sophisticated pre-closing reorganization
  • Represented a client as buyer in the acquisition of all of the equity of The Benefits Group of Haudenschield, Harrison and Blachek LLC, an insurance brokerage company
  • Represented a client as buyer in the acquisition of all of the equity of IPA 18 LLC, an insurance brokerage company

  • Represented an investor in the $20 million Series B investment in a media platform software company
  • Represented an investor in the $15 million Series A investment in a healthcare technology company
  • Represented an investor in the $25 million Series C investment in a data technology company
  • Represented an investor in the $25 million Series B investment in a data automation company
  • Represented an information technology company in its $37 million Series B round
  • Represented an investor in the $22 million Series B investment in a healthcare software company
  • Represented an investor in its $14 million secondary purchase
  • Represented a financial wellness technology company in its $6 million Series Seed round
  • Represented an investor in its $10 million Series Seed investment in an information technology company

  • Represented client in entry into a $25 million senior credit facility
  • Represented client in entry into a $285 million senior credit facility
  • Represented client in entry into an $820 million senior credit facility
  • Represented multiple clients in entry into acquisition financing arrangements

Credentials

Education
  • University of Tennessee College of Law, J.D., cum laude
  • Tusculum University, B.A., Business Administration
Bar Admissions/Licenses
  • Connecticut
  • Tennessee

Publications

The Loaning Shareholder
The Tennessee Journal of Business Law
October 2021

News

Holland & Knight Represents EmVenio Research in Acquisition by PCM Trials

Press Release / March 5, 2024

Holland & Knight Advises SkyKnight Capital on Investment in New Republic Partners

Press Release / January 24, 2022
Showing 1-2 of 2